Dr Rupinder  K Kanwar
Dr Rupinder K Kanwar
All India Institute of Medical Sciences (AIIMS), Bhopal, M.P. India
Verified email at
Cited by
Cited by
Recent advances on the roles of NO in cancer and chronic inflammatory disorders
JR Kanwar, RK Kanwar, H Burrow, S Baratchi
Current medicinal chemistry 16 (19), 2373-2394, 2009
Progress on Azadirachta indica Based Biopesticides in Replacing Synthetic Toxic Pesticides
S Chaudhary, RK Kanwar, A Sehgal, DM Cahill, CJ Barrow, R Sehgal, ...
Frontiers in plant science 8, 610, 2017
Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy
JR Kanwar, WP Shen, RK Kanwar, RW Berg, GW Krissansen
Journal of the National Cancer Institute 93 (20), 1541-1552, 2001
Chimeric aptamers in cancer cell-targeted drug delivery
JR Kanwar, K Roy, RK Kanwar
Critical reviews in biochemistry and molecular biology 46 (6), 459-477, 2011
Targeting survivin in cancer: the cell-signalling perspective
JR Kanwar, SK Kamalapuram, RK Kanwar
Drug discovery today 16 (11-12), 485-494, 2011
Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions
JR Kanwar, K Roy, Y Patel, SF Zhou, MR Singh, D Singh, M Nasir, ...
Molecules 20 (6), 9703-9731, 2015
Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal
JR Kanwar, X Sun, V Punj, B Sriramoju, RR Mohan, SF Zhou, A Chauhan, ...
Nanomedicine: Nanotechnology, Biology and Medicine 8 (4), 399-414, 2012
Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy
M Puri, I Kaur, RK Kanwar, RC Gupta, A Chauhan, JR Kanwar
Current Molecular Medicine 9 (9), 1080-1094, 2009
Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis
JR Kanwar, RK Kanwar, GW Krissansen
Brain 127 (6), 1313-1331, 2004
Recent advances in anti-survivin treatments for cancer
RK Kanwar, CH A Cheung, JY Chang, JR Kanwar
Current medicinal chemistry 17 (15), 1509-1515, 2010
Survivin signaling in clinical oncology: a multifaceted dragon
JR Kanwar, SK Kamalapuram, RK Kanwar
Medicinal research reviews 33 (4), 765-789, 2013
Temporal expression of heat shock proteins 60 and 70 at lesion-prone sites during atherogenesis in ApoE-deficient mice
RK Kanwar, JR Kanwar, D Wang, DJ Ormrod, GW Krissansen
Arteriosclerosis, thrombosis, and vascular biology 21 (12), 1991-1997, 2001
‘Iron‐saturated’lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy
JR Kanwar, KP Palmano, X Sun, RK Kanwar, R Gupta, N Haggarty, ...
Immunology and cell biology 86 (3), 277-288, 2008
Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
JR Kanwar, B Sriramoju, RK Kanwar
International journal of nanomedicine, 3259-3278, 2012
Molecular and biotechnological advances in milk proteins in relation to human health
JR Kanwar, RK Kanwar, X Sun, V Punj, H Matta, SM Morley, A Parratt, ...
Current Protein and Peptide Science 10 (4), 308-338, 2009
Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer
N Subramanian, V Raghunathan, JR Kanwar, RK Kanwar, SV Elchuri, ...
Molecular vision 18, 2783, 2012
Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer
JA Gibbons, JR Kanwar, RK Kanwar
BMC cancer 15 (1), 1-16, 2015
Lactoferrin and cancer in different cancer models
JA Gibbons, RK Kanwar, JR Kanwar
Frontiers in Bioscience-Scholar 3 (3), 1080-1088, 2011
Clinical aspects for survivin: a crucial molecule for targeting drug-resistant cancers
N Singh, S Krishnakumar, RK Kanwar, CHA Cheung, JR Kanwar
Drug discovery today 20 (5), 578-587, 2015
LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging
K Roy, RK Kanwar, JR Kanwar
Biomaterials 71, 84-99, 2015
The system can't perform the operation now. Try again later.
Articles 1–20